- Professional gathering in the field of aesthetics on July 5th
- Highlighting a case study of 메이저 바카라사이트 홈런’s aesthetic products
[by Yu, Suin] 메이저 바카라사이트 홈런 of Huons Group will host an academic gathering to showcase its product competitiveness.
Humedix Co., Ltd. announced on June 4 that it has begun recruiting participants for its upcoming HART 메이저 바카라사이트 홈런, which will focus on case studies in the field of aesthetics. The event is scheduled to take place on July 5 at the Grand InterContinental Seoul Parnas.
The symposium will highlight the latest Humedix products to medical professionals. It will feature skin booster ‘Elravie Re2O,’ based on acellular allogeneic dermis (hADM). Since Elravie Re2O’s domestic launch in November last year, Humedix has conducted various online and offline academic marketing activities, and it is being used in more than 300 dermatology clinics nationwide to improve skin.
In November last year, Humedix signed a distribution agreement with L&C Bio Co., Ltd. (L&C Bio) and secured domestic rights to sell Elravie Re2O to dermatologists and clinics. Elravie Re2O features L&C Bio’s patented human tissue processing technology, also known as ‘Alloclean Technology.’ It has improved safety and effectiveness by removing factors that induce cell and immune rejection responses while maintaining the tissue's unique 3D structure.
Humedix will also introduce HA filler ‘Elravie Premier,’ botulinum toxin ‘LIZTOX,’ drug injection device ‘Dermashine Pro,’ bio cosmeceutical ‘Cell exosome’, as well as a variety of aesthetic products at the symposium.
The 메이저 바카라사이트 홈런 will gather 120 prominent healthcare professionals (HCP) from Korea and abroad to share aesthetic insights, academic knowledge, and clinical know-how. The 메이저 바카라사이트 홈런 will be chaired by Dr. Je-young Park from Oracle Skin Clinic, and case presentations will be delivered by Dr. Eun Yeon Kim from Beauty Bar Plastic Surgery Clinic and Dr. Sang-yub Kim from JF Dermatology Clinic.
The official title of the symposium, HART, stands for ‘Humedix experts in Aesthetic Regeneration & Technology.’ It symbolizes Humedix’s pursuit of aesthetic regeneration and expertise in advanced technology, while also embodying its commitment to leading the future value of aesthetic medicine.
Humedix’s HART Symposium will be held at Orchid Ballroom at Grand InterContinental Seoul Parnas on July 5, where medical experts in the field of aesthetics will share their opinions on recent trends.
Humedix’s CEO Kang Min-jong said, “We hope that this HART symposium will be meaningful to all participants to showcase the competitiveness of our next-generation skin booster ‘Elravie Re2O,’ provide practical assistance in the clinical setting, and present new direction in the aesthetic field. We will continue to host academic symposiums in the future to share high-quality trends and clinical know-how with healthcare professionals.”